F757 in Montana. Pick another state for the same tag.
Against expectation — 2025
Montana cites F757 less often than its own record predicts
Versus expected share0.20×
0.20 times the national share — cited less often here than elsewhere.
Share of Montana citations0.16%
Of every deficiency written in Montana in 2025, this is the portion that was F757.
Montana0.16%
National0.79%
Share of all citations that were F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F757 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
J · Immediate jeopardy, isolatedMarch 26, 2026
Based on interview and record review, the facility nursing staff failed to ensure a resident's anticoagulant medication was clarified on admission for 1 (#36) of 19 sampled and supplemental residents, and the resident received a medication that was discontinued while in the hospital before being admitted . Therefore, the medication was unnecessary and should not have been provided to the resident. The resident experienced a significant change and decline in status due to the medication being given, which resulted in a low hemoglobin of 6.9 g/dl and required a blood transfusion. On 3/25/26 at 4:22 p.m., the facility Administrator and Office Manager were notified of an immediate jeopardy situation for F757. This involved one resident, #36. …
Based on interview and record review, the facility failed to ensure medications were free from unnecessary use by administering Narcan (naloxone) without a physician order or documented clinical indication for 1 (#4) of 1 resident reviewed for unnecessary medications. The failure resulted in precipitated opioid withdrawal symptoms, increased resident distress, and hospitalization, and the resident received additional medical treatment. Findings include: Review of a facility-reported incident submitted to the State Survey Agency on 5/18/26 showed resident #4, a hospice resident receiving comfort-focused treatment, was found unresponsive, and a staff member administered Narcan (naloxone). …
D · No harm, potential for more than minimal, isolatedJune 4, 2026
Based on interview and record review, the facility failed to ensure monitoring was in place for a resident for adverse consequences associated with the use of an anticoagulant medication that increased the risk of unrecognized adverse drug consequences and complications associated with anticoagulant therapy, for 1 (#5) of 14 residents sampled. Findings includeDuring an interview on 6/2/26 at 10:24 a.m., resident #5 said she was taking a blood thinner because staff suspected she had a blood clot.During an interview on 6/2/26 at 2:52 p.m., staff member P stated that when a resident received an anticoagulant medication, staff monitored for signs of bleeding and ensured the required laboratory work was completed. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction